Search Results 261-270 of 5977 for albumin

1. Analysis of Group 2 Innate Lymphoid Cells in Peripheral Blood - Mayo Clinic

   The primary objective of this study is to investigate the contribution of group 2 innate lymphoid cells (ILC2s) to the immunologic mechanisms of chronic airway ...

2. SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients - Mayo Clinic

   Serum calcium (corrected for albumin) level above the ULN range (treatment of hypercalcemia is allowed and subject may enroll if hypercalcemia returns to normal ...

3. Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy - Mayo Clinic

   Patients with serum albumin < 2.5 g/dl at baseline. Patients with white blood cell count (WBC) < 3.0 x109th/L at baseline. Patients with platelet count ...

4. Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome - Mayo Clinic

   Known or suspected hypersensitivity to the investigational product, or to any excipients of the investigational product or placebo (albumin);; A known ...

5. Shear Wave Elastograph and Contrast Enhanced Ultrasound for the Treatment of Lymphedema - Mayo Clinic

   Participation eligibility · Pregnant or nursing women. · Known or suspected hypersensitivity to microbubble contrast agent, perflutren, blood products, albumin, ...

6. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

   ... albumin ≥3.2g/dL lipase and amylase ≤2.0 × ULN and no radiologic (on baseline anatomical imaging) or clinical evidence of pancreatitis. Prior treatment ...

7. Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   Documented serum albumin <3 g/dL at Screening, and within 72 hours prior to first dose if first dose occurs more than 72 hours post screening (both labs at ...

8. 177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer - Mayo Clinic

   Albumin ≥ 2.5 g/dL 13. Candidates for change in ARDT as assessed by the treating physician. Exclusion Criteria: Participants meeting any of the following ...

9. A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors - Mayo Clinic

   Albumin >2.8 grams per deciliter (g/dL). Documented virology status of hepatitis, as confirmed by screening hepatitis B surface antigen (HBsAg), antibody to ...

10. Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG - Mayo Clinic

    Synthetic liver dysfunction (albumin deficiency < 2.8 mmol/L) at screening; or 4. Diagnosis of liver fibrosis (Fibroscan > 7 kPa) confirmed by liver ...